Background: Liquid nitrogen endoscopic spray cryotherapy can safely and effectively eradicate high-grade dysplasia in Barrett's esophagus (BE-HGD). Long-term data on treatment success and safety are lacking.
Objective: To assess the long-term safety and efficacy of spray cryotherapy in patients with BE-HGD.
Design: Single-center, retrospective study.
Setting: Tertiary-care referral center.
Patients: A total of 32 patients with BE-HGD of any length.
Intervention: Patients were treated with liquid nitrogen spray cryotherapy every 8 weeks until complete eradication of HGD (CE-HGD) and intestinal metaplasia (CE-IM) was found by endoscopic biopsy. Surveillance endoscopy with biopsies was performed for at least 2 years.
Main Outcome Measurements: CE-HGD, CE-IM, durability of response, disease progression, and adverse events.
Results: CE-HGD was 100% (32/32), and CE-IM was 84% (27/32) at 2-year follow-up. At last follow-up (range 24-57 months), CE-HGD was 31/32 (97%), and CE-IM was 26/32 (81%). Recurrent HGD was found in 6 (18%), with CE-HGD in 5 after repeat treatment. One patient progressed to adenocarcinoma, downgraded to HGD after repeat cryotherapy. BE segment length ≥3 cm was associated with a higher recurrence of IM (P = .004; odds ratio 22.6) but not HGD. No serious adverse events occurred. Stricture was seen in 3 patients (9%), all successfully dilated.
Limitations: Retrospective study design, small sample size.
Conclusion: In patients with BE-HGD, liquid nitrogen spray cryotherapy has an acceptable safety profile and success rate for eliminating HGD and IM and is associated with a low rate of recurrence or progression to cancer with long-term follow-up.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gie.2013.03.002 | DOI Listing |
Introduction Bronchoscopic spray cryotherapy (SCT) is a novel treatment showing promise for chronic bronchitis (CB), characterized by excessive mucus secretion and productive cough. A large animal model for preclinical research of SCT is lacking, and its treatment's efficacy and mechanisms for CB are not well understood. Methods Eight Labradors were exposed to 200 ppm SO2 for 6 months to develop a CB model.
View Article and Find Full Text PDFJ Dent Anesth Pain Med
December 2024
Department of Pediatric and Preventive Dentistry, Kannur Dental College, Kannur, Kerala, India.
Background: Tooth hypersensitivity presents a significant clinical challenge in managing molar-incisal hypomineralization (MIH), potentially compromising the effectiveness of restorative treatments. Cryotherapy has emerged as a promising approach to reduce pain and inflammation. This study aimed to evaluate and compare the effects of cryotherapy as an adjuvant to nerve blocks in reducing operative pain and sensitivity in patients.
View Article and Find Full Text PDFVet Ophthalmol
November 2024
Department of Veterinary Ophthalmology, College of Veterinary Medicine, Konkuk University, Seoul, Korea.
Objective: To preliminarily evaluate the treatment efficacy of a temperature-adjustable cryotherapy device for chronic, recurrent blepharitis in dogs.
Animals Studied: Five dogs (eight eyes) of different breeds with blepharitis, which was unresponsive to systemic steroids.
Procedures: The dogs were subjected to ophthalmic examination, including Schirmer tear test-1 (STT-1), tear film break-up time (TFBUT) test, and slit-lamp biomicroscope examination.
F1000Res
October 2024
Department of Clinical Medicine, Kasr Alainy Faculty of Medicine, Cairo University, Giza, Giza Governorate, 112631, Egypt.
Background: Chronic rhinosinusitis (CRS) is a condition that affects 5-12% of the general population. Endoscopic sinus surgery (ESS) is the preferred treatment because of its few adverse effects and highest success rates. The most common post-operative consequences include synechia, nasal blockage, and disease recurrence.
View Article and Find Full Text PDFChin Med J Pulm Crit Care Med
September 2024
Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg 69126, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!